Skip to content
Clinical Trials – home
I.F.O. Istituti Fisioterapici Ospitalieri
Sponsor

I.F.O. Istituti Fisioterapici Ospitalieri

Italy Via Elio Chianesi N 53, 00144 Rome, Italy

About the sponsor

Metastatic colorectal cancer is a key area of interest, with trials centered on treatment response and disease control in advanced colorectal malignancy.

  • Objective response in advanced colorectal cancer
  • Tumour control and progression management
  • Systemic therapy for metastatic disease

Research activity in this field reflects a focus on therapeutic strategies for patients with disseminated gastrointestinal cancer.

About Specializations

I.F.O. Istituti Fisioterapici Ospitalieri runs clinical trials in conditions such as Vitiligo, Prostate cancer, Colorectal cancer metastatic, Transitional cell carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Prostate cancer

Recruiting

Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:I.F.O. Istituti Fisioterapici Ospitalieri

Vitiligo

Not yet recruiting

A study testing pioglitazone for adults with non-segmental vitiligo to see if it works and is safe when used with light therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Pioglitazone
  • Sponsor:I.F.O. Istituti Fisioterapici Ospitalieri

Study on Vinorelbine for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Vinorelbine
  • Sponsor:I.F.O. Istituti Fisioterapici Ospitalieri

Vitiligo

Not yet recruiting

Study on Pioglitazone for Adults with Non-Segmental Vitiligo

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Pioglitazone
  • Sponsor:I.F.O. Istituti Fisioterapici Ospitalieri

Study on Pembrolizumab and Cyclophosphamide for Patients with Metastatic Urothelial Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide Monohydrate
  • Sponsor:I.F.O. Istituti Fisioterapici Ospitalieri

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.